Peregrine Pharma (PPHM) Misses Q3 EPS by 1c

March 9, 2016 8:04 AM EST

Peregrine Pharma (NASDAQ: PPHM) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.71 million versus the consensus estimate of $7.96 million.

For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings